Revenue YoY
+17.44%
Operating Income YoY
+42.74%
Net Income YoY
+74.80%
Net Margin Δ
+562 bps
Net income bridge for Boston Scientific (BSX) — TTM through Q1 2026 vs TTM through Q1 2025
Δ Net income: $1.52B+74.80%
Profit bridge breakdown for Boston Scientific (BSX) — TTM through Q1 2026 vs TTM through Q1 2025
| Driver | Contribution | % of Δ |
|---|---|---|
| Prior Net Income | $2.03B | — |
| Revenue | $3.06B | +201.4% |
| Cost of Revenue | $601.00M | +39.5% |
| Operating Expenses | −$2.42B | -159.3% |
| Other Income / Expense | $23.00M | +1.5% |
| Income Tax | $270.00M | +17.8% |
| Net Income | $3.55B | — |
- Prior Net Income$2.03B
- Revenue$3.06B
- Cost of Revenue$601.00M
- Operating Expenses−$2.42B
- Other Income / Expense$23.00M
- Income Tax$270.00M
- Net Income$3.55B
Identity residual: −$15.00M (delta between driver sum and reported ΔNI)
Want the full P&L structure?Income Statement Waterfall
Frequently asked questions
Data & methodology
Boston Scientific (BSX) Key Financials
Charts, filings, and peer comparison for every metric
Income Statement
Balance Sheet
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation
Overview
Income Statement